Deferasirox

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69238-1487
  • Package NDC 69238-1487-3
  • Application number ANDA210727
  • SPL ID 0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7
  • SPL set ID a7ae9c31-e14f-4cf9-9ab3-850519f1a87c
  • UNII V8G4MOF2V9
  • RxCUI 1607784
  • RxCUI 1607792
  • RxCUI 1607796

What the source publishes

Labeler
Amneal Pharmaceuticals NY LLC
Active ingredients
Deferasirox
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69238-1487_0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7
{
  "name": "Deferasirox",
  "splId": "0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7",
  "labels": [
    {
      "setId": "a7ae9c31-e14f-4cf9-9ab3-850519f1a87c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7ae9c31-e14f-4cf9-9ab3-850519f1a87c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7ae9c31-e14f-4cf9-9ab3-850519f1a87c"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Amneal Pharmaceuticals NY LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (69238-1487-3)",
      "package_ndc": "69238-1487-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200615"
    }
  ],
  "productId": "69238-1487_0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "69238-1487",
  "deaSchedule": null,
  "genericName": "Deferasirox",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DEFERASIROX",
      "strength": "180 mg/1"
    }
  ],
  "applicationNumber": "ANDA210727",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200615",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000144",
      "N0000175522",
      "N0000185506",
      "N0000187062",
      "N0000182138"
    ],
    "unii": [
      "V8G4MOF2V9"
    ],
    "rxcui": [
      "1607784",
      "1607792",
      "1607796"
    ],
    "spl_set_id": [
      "a7ae9c31-e14f-4cf9-9ab3-850519f1a87c"
    ],
    "pharm_class_epc": [
      "Iron Chelator [EPC]"
    ],
    "pharm_class_moa": [
      "Iron Chelating Activity [MoA]",
      "Cytochrome P450 3A4 Inducers [MoA]",
      "Cytochrome P450 2C8 Inhibitors [MoA]",
      "Cytochrome P450 1A2 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Amneal Pharmaceuticals NY LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69238-1487_0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7"